A normal component of bone marrow that is detectable by silver staining methods in 73-81% of healthy individuals.
Increased reticulin is associated with a number of benign and malignant processes.
Thrombopoietic growth factor therapy can induce reticulin fibrosis in the bone marrow.
Reticulin fibrosis has been observed in trials of romiplostim and eltrombopag.